PC058.

What Is the Real Mode of Failure? Trends in Angio-Seal Adverse Events Reported to the MAUDE Database
Meghan Reeves, Michael F. Amendola. Virginia Commonwealth University Health System, Richmond, Va
Objectives: The Manufacturer and User Facility Device Experience (MAUDE) Database was established by the United States Food and Drug Administration to allow for voluntary reporting of adverse outcomes of medical devices. The Angio-Seal device (St. Jude Medical, Minnetonka, Minn) closure device is one of many devices reported to the database. We set out to determine whether defined failure mode (DFM; collagen plug, device handle, footplate, and/or sheath) at index deployment vs an undefined failure mode (UFM) had differing outcomes in terms adverse patient consequences and/or returned devices (Table) .
Methods: The MAUDE database was access from December 1, 2005, to December 1, 2016, at a single time point for entries related to the AngioSeal device. There were two different groups, the first with defined failure mode (DFM) at the time of deployment vs undefined failure mode (UFM). The time to report from index event, negative patient outcome (hematoma, surgery, further intervention, death), and devices returned to the manufacturer were collected.
Results: A total of 125 entries were found for the time period examined. Dividing the index events: of the entries with a defined failure mode, the stated cause was attributed to the collagen plug, device handle, footplate and sheath in 10% (n ¼ 3), 30% (n ¼ 9), 23% (n ¼ 7), and 37% (n ¼ 11) cases, respectively.
Conclusions: In examining the MAUDE database, we find an average of half of all entries had a negative patient outcome. When a defined failure mode was described, only a small percentage of devices were returned to the manufacturer. These data should be used to inform the vascular community at large of the small number of entries to this database that were heterogeneous entries. These data should encourage more active and accurate reporting of this and other closure devices.
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PC060. Reoperation Following Lower Extremity Amputation
Methods: From January 2013 to August 2015 (to ensure potential for a minimum of 1 year of postoperative data collection), the medical records of all patients undergoing lower extremity amputations at a single institution were reviewed. Readmission rates, procedural data, perioperative variables, and patient comorbidities were compared using SPSS software to analyze primary graft failure incidence rates, Pear- and/or contralateral (21.5%) amputation. There was a 26.2% rate of return to the operating room, with the most common procedure performed being a higher-level amputation. Independent risk factors on univariate analysis for reoperation included most significantly male gender, indication for procedure, level of amputation, wound infection/dehiscence, hematoma, and acute renal insufficiency. On multivariate regression with a goodness of fit value of .008, female gender and prior ipsilateral amputation were protective against return to the operating room, whereas presentation to the emergency department (odds ratio [OR], 8.1; 95% confidence interval [CI], 2.2-50), wound infection (OR, 11.4; 95% CI, 5.4-24.1), and wound dehiscence (OR, 4.5; 95% CI, 1.3-15.5) remained independently predictive of need for reoperation.
Conclusions: Emergent presentation with ongoing wound infection leads to an increased rate of reoperation. Higher-level amputation due to more distal prior ipsilateral amputation is a more definitive procedure with lower risk of need for return to the operating room. Patient counseling taking into account location of and indication for presentation along with prior surgical history may improve amputation level selection and thereby reduce rates of reoperation.
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